Athenecia Faggins
Advertisement
Dr. Athenecia Faggins is Director of Minaris Advanced Therapies
Articles by Athenecia Faggins
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Iovance’s Lifileucel Reaches 52% Response Rate in Biomarker-Selected Lung Cancer Subgroup
2
Lilly’s Retatrutide Doubles Ozempic’s Weight Loss in First Phase 3 Head-to-Head Trial
3
Genmab’s Petosemtamab Plus Pembrolizumab Cuts Risk of Death by 50% in Phase 3 Head and Neck Cancer Trial
4
Non-Aqueous Suspensions Could Push Antibody Concentrations Above 400 mg/mL, Says Nanoform’s Chris Worrall
5